3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Purpura, Thrombotic Thrombocytopenic
1
Interventions
caplacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Purpura, Thrombotic Thrombocytopenic
×
caplacizumab
×
Clear all
NCT02553317
2023-04-05
HERCULES
Sanofi
Phase 3
Completed
145 enrolled
20 charts
1 FDA